
About BioMedPartners
BioMedPartners is a Financial Services company based in Basel (Switzerland). Early to mid stage life sciences-focused VC firm investing in geographies such as Europe. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.
- Headquarters Basel, Switzerland
- SectorsFinancial Services
- Website biomedvc.com
People of BioMedPartners
10 people are tracked at BioMedPartners (3 in leadership, 7 in board & advisors).
| Name | Role | Group |
|---|---|---|
Thomas Möller | General Partner | Leadership |
Michael Wacker | General Partner | Leadership |
Markus Hosang | General Partner | Leadership |
Ulrich Geilinger | Member advisory board | Board & advisors |
Andrea Pfeifer | Chairwoman of the board | Board & advisors |
William M. Burns | Senior business & scientific advisor | Board & advisors |
Ulrich Vischer | Board member | Board & advisors |
Adam Cohen | Scientific Advisor | Board & advisors |
H.c. Henri B. Meier | Chairman of the board | Board & advisors |
Bernard Burkhalter | Member of the board | Board & advisors |
Complete people profiles for BioMedPartners
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomedpartners
Complete news archive for BioMedPartners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMedPartners
BioMedPartners is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.
